ATOSSA THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
ATOSSA THERAPEUTICS, INC. (ATOS) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $7.39 thousand as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2017-11-13
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $7.39K.
- 2017-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $4.93K.
- 2017-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $12.32K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2017-09-30 | $7.39K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $4.93K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $12.32K 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |